CTOs on the Move

Pediatric Home Services

www.pediatrichomeservice.com

 
We are dedicated to quality service for the medically fragile child. We service our patients based on each child's specific needs to develop their potential through clinical education and technical support. We believe it takes more than health care to
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Claudia Kuri
Chief Operating Officer Profile
Glenn Galloway
Executive VP Technology & Integrations Profile

Similar Companies

Gladstone Institutes

Gladstone`s mission is to drive a new era of discovery in disease-oriented science and to mentor tomorrow`s leaders in an inspiring and diverse environment.

Eyecare Partners

Eye Care Partners P.C. Located at 823 Franklin Street, Pella Iowa Penn Central Eye Clinic, Located inside Penn Central Mall, Oskaloosa Iowa

Swisslog Healthcare

Swisslog Healthcare provides integrated medication supply chain solutions to hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients` needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways.

Retirement Concepts

Retirement Concepts is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.